Quick Takeaways
- WASATCH ADVISORS LP filed SCHEDULE 13G/A for Esperion Therapeutics Inc COM (ESPR).
- Disclosed ownership: 3.5%.
- Date of event: 30 Sep 2025.
WASATCH ADVISORS LP - 30 Sep 2025 SCHEDULE 13G/A Report for Esperion Therapeutics Inc COM (ESPR)
- Filing Manager
- WASATCH ADVISORS LP
- Reporting Manager
- Wasatch Advisors LP
- Security
- Esperion Therapeutics Inc COM
- Symbol
- ESPR
- Shares outstanding
- 201,767,343 shares
- Disclosed Ownership
- 7,061,857 shares
- Ownership
- 3.5%
- Form type
- SCHEDULE 13G/A
- Filing time
- 12 Nov 2025, 15:32:33 UTC
- Date of event
- 30 Sep 2025
- Previous filing
- 07 Apr 2025
- Next filing
- 22 Apr 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"WASATCH ADVISORS LP disclosed 3.5% ownership in Esperion Therapeutics Inc COM (ESPR) on 30 Sep 2025."
What Changed
- Previous schedule filing date: 07 Apr 2025.
- Current filing was accepted on 12 Nov 2025, 15:32.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Wasatch Advisors LP | 3.5% | 7,061,857 | 6,219,311 | 0 | Mike Yeates | CEO |